TX enters its Q1 2026 results today with the most interesting tension sitting not in the lending market but in the gap between where analysts stand and where the stock has run.
Options positioning has shifted slightly more cautious heading into the event. The put/call ratio moved to 0.43, about 1.5 standard deviations above its 20-day average of 0.38 — still well below the 52-week high of 1.01, but a meaningful step up from the complacent call-heavy positioning that dominated through late March. The stock has climbed 11% over the past month to $44.11, adding 3% in the last session alone, and is up roughly 14% year-to-date. That rally has outpaced the earnings-estimate revision trend: the 30-day EPS momentum factor ranks in just the 25th percentile, and the 90-day reading is even weaker at the 11th.
The analyst debate is unresolved — and the consensus mean target of $43.46 now sits fractionally below the current price, a reversal that frames the print as a valuation test. UBS nudged its target to $41 in early April while holding Neutral. Scotiabank downgraded to Sector Perform in late March, keeping its $40 target unchanged. Wells Fargo maintains Underweight with a $33 target. Against that, JP Morgan holds Overweight and previously raised its target to $40.50. The bull case rests on Ternium's exposure to structural Mexican steel demand and a net cash position — the company carried net cash of roughly $179 million on the most recent quarter's estimate, a meaningful buffer in a capital-intensive sector. The bear case centres on weak EPS revision momentum, tariff-driven cost uncertainty, and a P/E that has re-rated upward by roughly one turn over the past month to 10.6x, compressing the margin of safety that attracted value buyers earlier in the year.
The ownership structure adds a specific wrinkle. The Rocca family vehicle controls 75% of shares, leaving a thin public float relative to the headline market cap of ~$8.4 billion. Lazard and Donald Smith — both value-oriented managers — hold meaningful positions among the freely traded shares. The forward yield factor ranks in the 86th percentile, reflecting the stock's dividend history relative to peers, though the most recent dividend data is stale and no current payout announcement has been captured.
Short interest is minimal — just 0.29% of float — and borrow conditions are effectively loose, with availability far exceeding current short demand. That removes any squeeze dynamic from the equation entirely.
The print will test whether Q1 revenue and EBITDA — estimated near $3.96 billion and $464 million respectively — can justify a stock that has re-rated ahead of positive fundamental revisions, at a moment when the analysts who cover it most closely have been moving targets lower, not higher.
See the live data behind this article on ORTEX.
Open TX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
